Low Endotoxin Recovery
Assessment of PDA Technical Report No. 82 and Demasking of Endotoxins With Dedicated Sample Treatment
SPEAKERS
Kevin Williams
Senior Scientist Endotoxin | bioMérieux
Dr. Christian Faderl
Project Coordinator Endotoxin | LER Services | bioMérieux
Webinar Overview
The Parenteral Drug Association (PDA) has recently published Technical Report No. 82 (TR82) on the topic of Low Endotoxin Recovery (LER), providing both consensus to the science and data behind the analytical issue, as well as to analytical and mitigation strategies.
In this webinar, Kevin Williams and Dr. Christian Faderl from bioMérieux, explain the important implications of TR82 as well as presenting the ENDO-RS® sample preparation technology for demasking endotoxin in affected biologics, as described in Case Study 7 of TR82.
Want information on our endotoxin testing solutions?
Complete the form below to get in touch with our team. A bioMérieux expert will be in touch using the contact information you provide. By providing your information, you agree to receive additional emails from bioMérieux about endotoxin testing.
To find out more about the management of your personal data and to exercise your rights, see our privacy policy.